A real-world study on persistence with ofatumumab in Canadian patients with multiple sclerosis.
Saved in:
| Title: | A real-world study on persistence with ofatumumab in Canadian patients with multiple sclerosis. |
|---|---|
| Authors: | Selchen D; Barlo MS Centre, Division of Neurology, Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada., Grant R; Novartis Pharmaceuticals Canada Inc., Montreal, Canada. Electronic address: rebecca.grant@novartis.com., Magnussen C; Novartis Pharmaceuticals Canada Inc., Montreal, Canada., Murray J; IQVIA Solutions Canada Inc., Ontario Canada., Neish CS; IQVIA Solutions Canada Inc., Ontario Canada. |
| Source: | Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2026 Mar; Vol. 107, pp. 106976. Date of Electronic Publication: 2026 Jan 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2211-0356 |
|---|---|
| DOI: | 10.1016/j.msard.2026.106976 |
